Last updated: 02/06/2024 15:30:19

Short term outcomes of Donation after Circulatory Death (DCD) renal transplantation in the United Kingdom

GSK study ID
205930
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Short term outcomes of Donation after Circulatory Death (DCD) renal transplantation in the United Kingdom
Trial description: This is a retrospective, observational medical chart review study of subjects who are first or second time recipients of single kidney-only transplants from 2010 through 2015. The objective is to obtain historical standard of care data on functional outcomes (frequency of delayed graft function, serial creatinine values, frequency of dialysis episodes, graft survival and mortality) within the first year post-transplant. Data will be provided from the UK Transplant Registry held by NHS Blood and Transplant (NHSBT) and medical records from transplant centres in the UK.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Frequency of delayed graft function in first 7 days post-transplantation

Timeframe: From transplant to Day 7 (assessed for approximately 7 days)

Number of dialysis events in first 30 days after transplantation

Timeframe: From transplant to Day 30 (assessed for approximately 30 days)

Frequency of rejection episodes in one year of follow-up

Timeframe: From transplant to 12 month (assessed for approximately 1 year)

One year graft survival

Timeframe: From transplant to 12 month (assessed for approximately 1 year)

All-cause mortality in one year

Timeframe: From transplant to 12 month (assessed for approximately 1 year)

Longitudinal serum creatinine in one year post transplantation

Timeframe: From transplant to 12 month (assessed for approximately 1 year)

Longitudinal eGFR levels in one year post transplantation

Timeframe: From transplant to 12 month (assessed for approximately 1 year)

Secondary outcomes:
Not applicable
Interventions:
  • Procedure: Kidney transplant
  • Enrollment:
    0
    Primary completion date:
    2018-07-12
    Observational study model:
    Cohort
    Time perspective:
    Retrospective
    Clinical publications:
    Heide Stirnadel-Farrant, George Mu, Selin Cooper-Blenkinsop, Rosemary O Schroyer, Kevin S Thorneloe, Ewen M Harrison, Susan MS Andrews.Predictive value of delayed graft function definitions following donation after circulatory death renal transplantation in the United Kingdom.Transpl Res Risk Manag.2022;2022(14):21-33 DOI: https://doi.org/10.2147/TRRM.S320221
    Medical condition
    Kidney Transplantation (status post)
    Product
    GSK1070806
    Collaborators
    National Health Service Blood and Transplant (NHS BT)
    Study date(s)
    April 2017 to December 2018
    Type
    Observational
    Phase
    2

    Participation criteria

    Sex
    Female & Male
    Age
    18+ years
    Accepts healthy volunteers
    none
    • Subjects recipient of DCD Kidney
    • Subjects recipient of first or second time and single kidney-only transplant
    • No exclusion criteria

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Cambridge, United Kingdom, CB2 0QQ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edinburgh, United Kingdom, EH16 4SA
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glasgow., United Kingdom, G51 4TF
    Status
    Study Complete
    Location
    GSK Investigational Site
    Newcastle upon Tyne., United Kingdom, NE7 7DN
    Status
    Study Complete

    Study documents

    Study report synopsis
    Available language(s): English
    Protocol
    Available language(s): English
    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    2018-07-12
    Actual study completion date
    2018-07-12

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website